IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.530
-0.030 (-1.92%)
At close: Apr 28, 2026, 4:00 PM EDT
1.530
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
IN8bio Employees
IN8bio had 17 employees as of December 31, 2025. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,143,529
Market Cap
15.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Citius Pharmaceuticals | 23 |
| SeaStar Medical Holding | 17 |
| Theriva Biologics | 16 |
| NewcelX | 15 |
| Genenta Science | 9 |
| Phio Pharmaceuticals | 6 |
| Pasithea Therapeutics | 5 |
| Cadrenal Therapeutics | 4 |
INAB News
- 12 days ago - IN8bio Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts
- 25 days ago - IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026 - GlobeNewsWire
- 2 months ago - IN8bio Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - IN8bio to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer - GlobeNewsWire
- 2 months ago - IN8bio Transcript: Noble Capital Markets’ Emerging Growth Virtual Equity Conference - Transcripts
- 3 months ago - IN8bio to Present at Upcoming Investor and Scientific Conferences in February - GlobeNewsWire